雅虎香港 搜尋

搜尋結果

  1. public.gsk.co.uk › contact-us › report-suspected-side-effectReport suspected side effect

    To report a possible side effect, either call us at 0800 221 441 or send an email to uksafety@gsk.com. July 2021 | NP-GB-NA-WCNT-210007. Form for UK members of the public and patients that have been prescribed a GSK medicine or vaccine to report a suspected side effect.

  2. This site provides information on GSK medicines and vaccines for members of the UK public, patients and their carers. You are now leaving GSK’s website This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites

  3. public.gsk.co.uk › products › bexseroBexsero | GSK Public

    • What Is Bexsero?
    • How Does It Work?
    • Safety
    Bexsero is a Meningococcal group B Vaccine.
    It contains four different components from the surface of the bacteria Neisseria meningitidisgroup B.
    It is given to individuals from 2 months of age and older to help protect against disease caused by the Neisseria meningitidisgroup B bacteria. These bacteria can cause serious, and sometimes life-...
    The vaccine works by specifically stimulating the body’s natural defense system of the vaccinated person. This results in protection against the disease.
    Talk to your doctor, nurse or pharmacist before you or your child receive Bexsero.
    A full list of side effects can be found in the patient information leaflet.
    Do not use Bexsero if you or your child are allergic to the active substances or any of the other ingredients of this vaccine.
    Very common side effects (these may affect more than 1 in 10 people) for infants and children (up to 10 years of age) include fever (≥38ºC), loss of appetite, tenderness or discomfort at the inject...
    A common side effect (this may affect less than 1 in 10 people to more than 1 in 100 people) for infants and children (2 to 10 years of age) is a skin rash.
  4. October 2023 | NP-GB-BOI-WCNT-230001 (V1.0) Information on Boostrix-IPV (diphtheria, tetanus, pertussis (acellular) and poliomyelitis (inactivated)) for members of public including summary of product characteristics and patient information leaflet.

  5. Information on Priorix (Measles, Mumps and Rubella vaccine (live)) for members of public including summary of product characteristics and patient information leaflet You are now leaving GSK’s website This link will take you to a non-GSK website. GSK does not